PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links


Article published in Urologia Polska 2000/53/2.

authors

Marian Sulik 1, Barbara Darewicz 2, Andrzej Ku¼micz 3, Jaros³aw Szymański 3
1 Zak³ad Anatomii Patologicznej AM w Bia³ymstoku
Kierownik: prof. dr hab. B. Musiatowicz
2 Klinika Urologii AM w Bia³ymstoku
Kierownik: prof. dr hab. J. Darewicz
3 Zak³ad Radiologii Wojódzkiego Szpitala Zespolonego im. J. ¦niadeckiego
w Bia³ymstoku
Dyrektor: dr n. med. B. Dziatkiewicz

keywords

prostate PIN

references

  1. [1] Alexander, E. E., Qian, ]., Wollan, P. C, Myers, R. P., Bostwick, D. G.:
  2. Prostatic intraepithe³ial neoplasia does not appear to raise serum Prostate-specific
  3. antigen concentration. Urology 1996, 47, 683-688.
  4. [2] Bostwick, D. G.: Premalignant lesions of the prostate. Semin. Diagn. Pathol.
  5. 1988, 5, 240-253.
  6. [3] Bostwick, D. G., Brawer, M. K.: Prostatic intraepithe³ial neoplasia and early
  7. invasion in prostate cancer. Cancer 1987, 59, 788-794.
  8. [4] Bostwick, D. G., Pacelli, A., Blute, M., Roche, P., Murphy, G. P.: Pro-
  9. state specific membrane antigen expression in prostatic intraepithe³ial neoplasia
  10. and adenocarcinoma: a study of 184 cases. Cancer, 1998, 82, 2256-2261.
  11. [5] Bostwick, D. G'., Qian, J., Frankel, K.: The incidence of high grade prostatic
  12. intraepithe³ial neoplasia in needle biopsies. J. Urol. 1995,154,1791-1794.
  13. [6] Bostwick, D.G., Iczkowski, K. A.: Minimal criteria for the diagnosis of pro-
  14. state cancer on needle biopsy. Ann. Diagn. Pathol. 1997,1,104-129.
  15. [7] Brawer, M.: Prostatic intraepithe³ial neoplasia: a premalignant lesion. J. Cell.
  16. Biochem. Suppl. 1992,16G, 171-174.
  17. [8] Drago, J. R., Mostofi, F. K., Lee, F.: Introductory remarks and workshop Sum-
  18. mary. Urology 1989, 34(Suppl.), 2-3.
  19. [9] Epstein, J. I.: Prostate Biopsy Interpretation. Prostatic intraepithe³ial neoplasia.
  20. Lippincot - Raven. Philadelphia, New York 1995, 37-63.
  21. [10] Foster, C. S., Bostwick, D. G.: Pathology of the prostate. Prostatic intraepithe-
  22. ³ial neoplasia. W.B. Saunders Company. Philadelphia, London 1998, 95-113.
  23. [11] Iczkowski, K. A, MacLennan G. T, Bostwick D. G: Atypical smali acinar
  24. proliferation suspicious for malignancy in prostate needle biopsies: clinical signifi-
  25. cance in 33 cases. Am. J. Surg. Pathol. 1997, 21,1489-1495.
  26. [12] McNeal, J. E.: Origin and derelopment of carcinoma in the prostate. Cancer 1969,
  27. 23, 24-34.
  28. [13] McNeal, J. E., Bostwick D. G.: Intraductal dysplasia: A premalignant lesion of
  29. prostate. Hum. Pathol. 1986,17, 64-71.
  30. [14] Mostofi, F. K., Sesterhenn, I. A., Davis, C. J. Jr: Malignant change in hy-
  31. perplastic prostate glands: the AFIP expeńence. Urology 1989,34(SuppL), 49-51.
  32. [15] Pacelli, A., Bostwick, D. G.: Clinical significance of high-grade prostatic in-
  33. traepithe³ial neoplasia in transurethral resection specimens. Urology 1997,50,355-
  34. 359.
  35. [16] Qian, J., Wollan, P., Bostwick, D. G.: The extent and multicentricity of high-
  36. grade prostatic intraepithe³ial neoplasia in Clinically localized prostatic adenocarci-
  37. noma. Hum. Pathol. 1997, 28,143-148.